SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-053953
Filing Date
2021-11-03
Accepted
2021-11-03 16:10:59
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-10q_20210930.htm   iXBRL 10-Q 2433025
2 EX-10.1 hrtx-ex101_116.htm EX-10.1 46532
3 EX-31.1 hrtx-ex311_7.htm EX-31.1 21773
4 EX-31.2 hrtx-ex312_6.htm EX-31.2 21066
5 EX-32.1 hrtx-ex321_8.htm EX-32.1 17913
6 GRAPHIC glci2gqxsjk4000001.jpg GRAPHIC 40735
  Complete submission text file 0001564590-21-053953.txt   8010261

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20210930.xsd EX-101.SCH 39796
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20210930_cal.xml EX-101.CAL 42912
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20210930_def.xml EX-101.DEF 140444
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20210930_lab.xml EX-101.LAB 357607
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20210930_pre.xml EX-101.PRE 262972
12 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-10q_20210930_htm.xml XML 1485437
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 211375453
SIC: 2834 Pharmaceutical Preparations